Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 96.00
-0.40 (-0.41%)
Jul 16, 2026, 1:30 PM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 16.15 billion as of July 15, 2026. Its market cap has decreased by -38.89% in one year.
Market Cap
16.15B
Enterprise Value
15.41B
Revenue
31.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
96.00
Market Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 16.15B, an increase of 275.93%. That is a compound annual growth rate of 12.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 16.15B | -50.72% |
| Dec 31, 2025 | 32.77B | -22.40% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 23.76B |
| Oneness Biotech | 23.49B |
| Sunmax Biotechnology | 20.75B |
| ACRO Biomedical | 18.30B |
| TaiMed Biologics | 17.54B |
| Ever Supreme Bio Technology | 16.49B |
| Medigen Vaccine Biologics | 14.81B |
| TCM Biotech International | 14.35B |